Indications for COPAXONE:
Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Supervise 1st dose. Give only by SC inj into arms, abdomen, hips, thighs. Rotate inj sites. ≥18yrs: 20mg once daily or 40mg three times weekly (at least 48hrs apart). The 20mg/mL and 40mg/mL injections are not interchangeable.
<18yrs: not established.
Risk of immediate post-injection reactions. May potentially interfere with immune functions. Pregnancy. Nursing mothers.
Inj site reactions, vasodilatation, rash, dyspnea, chest pain, asthenia, infection, pain, nausea, anxiety; rare: lipoatrophy, skin necrosis.
Single-dose prefilled syringes 20mg/mL—30; 40mg/mL—12